Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease hypoglycemia
Phenotype |diabetes mellitus
Sentences 61
PubMedID- 21680991 Recognition, prevention, and proactive management of hypoglycemia in patients with type 1 diabetes mellitus.
PubMedID- 22291471 For patients with type 2 diabetes mellitus, the incidence of severe hypoglycemia was 0.3 (median) episodes per 100 person-years for insulin analogs and 1.4 for human regular insulin.
PubMedID- 26268308 diabetes mellitus (dm) is associated with severe hypoglycemia events (shes) that vary in severity and resource consumption.
PubMedID- 25556593 Insulin-induced hypoglycemia in a patient with insulin-dependent diabetes mellitus resulted in chronic pontine dysfunction [10], confirming the unique vulnerability of the pons to hypoglycemia.
PubMedID- 21339838 Exercise-related hypoglycemia in diabetes mellitus.
PubMedID- 23577069 Influence of erythropoietin on cognitive performance during experimental hypoglycemia in patients with type 1 diabetes mellitus: a randomized cross-over trial.
PubMedID- 24030920 The incidence of mild and severe hypoglycaemia in patients with type 2 diabetes mellitus treated with sulfonylureas: a systematic review and meta-analysis.
PubMedID- 24790575 Therefore, a more cautious follow-up and education are needed to impede and treat hypoglycemia in children with diabetes mellitus.
PubMedID- 20650471 Conclusions: a basal insulin rate reduction was safe and effective in raising post-exercise nocturnal bg nadir and in reducing hypoglycemia in children with type 1 diabetes mellitus.
PubMedID- 23781301 Association of igf1 with glycemic control and occurrence of severe hypoglycemia in patients with type 1 diabetes mellitus.
PubMedID- 23683002 Aim: to compare the impact of diabetes duration on hypoglycaemia in patients with type 2 diabetes mellitus (t2dm) treated with insulin glargine or nph insulin.
PubMedID- 24185751 Bariatric teams performing lsg for morbid obesity should heighten their sensitivity to postoperative hypoglycemia, even in patients with type 2 diabetes mellitus.
PubMedID- 25779865 Aims: accurate assessment of blood glucose fluctuation is essential for managing blood glucose control while avoiding hypoglycemia in patients with diabetes mellitus.
PubMedID- 23916172 Position statement: hypoglycemia management in patients with diabetes mellitus.
PubMedID- 25937182 Increasing trend in emergency department visits for hypoglycemia from patients with type 2 diabetes mellitus in taiwan.
PubMedID- 25325279 Optimal candidates for the switch from glimepiride to sitagliptin to reduce hypoglycemia in patients with type 2 diabetes mellitus.
PubMedID- 25415670 Seasonal variations of severe hypoglycemia in patients with type 1 diabetes mellitus, type 2 diabetes mellitus, and non-diabetes mellitus: clinical analysis of 578 hypoglycemia cases.
PubMedID- 23067027 Low risk of severe hypoglycaemia in patients with type 2 diabetes mellitus starting insulin therapy with premixed insulin analogues bid in outpatient settings.
PubMedID- 23926410 Nateglinide is effective for diabetes mellitus with reactive hypoglycemia in a child with a compound heterozygous abcc8 mutation.
PubMedID- 23434929 Paradoxically, somatostatin concentrations are elevated at baseline and rise further during hypoglycemia in patients with type 1 diabetes mellitus who are on exogenous insulin (19).
PubMedID- 24122616 The performance of the proposed r-bbnn algorithm was evaluated by an application to the field of medical diagnosis using real hypoglycemia episodes in patients with type 1 diabetes mellitus.
PubMedID- 25263824 Quality of life and fear for hypoglycaemia in patients with type 2 diabetes mellitus.
PubMedID- 23692715 Neurocognitive functions were negatively affected by early onset of diagnosis, poor glycemic control and frequent hypoglycemia in children with type i diabetes mellitus.
PubMedID- 21199269 Aim: the objective of this systematic review and meta-analysis was to assess the effect of pramlintide on glycemic control, weight and incidence of nausea and hypoglycaemia in patients with type 2 diabetes mellitus (t2dm) and in obese patients without diabetes (obp).
PubMedID- 22784848 Population-based study of hypoglycemia in patients with type 1 diabetes mellitus requiring emergency medical services.
PubMedID- 20518101 Diabetes: nocturnal hypoglycemia is frequent in patients with type 1 diabetes mellitus.
PubMedID- 26417415 Thus, further studies are required regarding fear of hypoglycemia in patients with type 2 diabetes mellitus.
PubMedID- 23063035 Background: self-monitoring of blood glucose (smbg) and continuous glucose monitoring (cgm) have been proven effective in improving hemoglobin a1c (hba1c) and in reducing hypoglycemia in patients with type 1 diabetes mellitus (t1dm).
PubMedID- 24450135 [case report; a case of type 2 diabetes mellitus with frequent hypoglycemia due to insulin antibodies after switching insulin product].
PubMedID- 23683963 Hospitalizations due to severe hypoglycemia in patients with diabetes mellitus in spain.
PubMedID- 24023652 The aim of this study was to investigate whether copeptin increases upon hypoglycaemia in patients with type 1 diabetes mellitus and is associated with the degree of hypoglycaemia awareness.
PubMedID- 26229480 hypoglycemia hospitalization frequency in patients with type 2 diabetes mellitus: a comparison of dipeptidyl peptidase 4 inhibitors and insulin secretagogues using the french health insurance database.
PubMedID- 22047939 The effect of short-term use of the guardian rt continuous glucose monitoring system on fear of hypoglycaemia in patients with type 1 diabetes mellitus.
PubMedID- 20920434 Conclusions: this article offers, for the first time, a method for smoothly reducing insulin delivery rate to prevent hypoglycemia in individuals with type 1 diabetes mellitus based on a mathematically formal assessment of hypoglycemic risk.
PubMedID- 26289736 diabetes mellitus (dm) is associated with severe hypoglycemia events (shes) that vary in severity and resource consumption.
PubMedID- 25782322 It is concluded that evaluation of quality of life and hypoglycemia-related symptoms in patients with type 2 diabetes mellitus on basal-bolus insulin therapy allows for comprehensive estimation of the effectiveness of therapy on an individual basis.
PubMedID- 23753199 Importance: hypoglycemia commonly occurs in patients with diabetes mellitus (dm) and may negatively influence cognitive performance.
PubMedID- 23215826 Is reduction in peak heart rate while exercising a sign of hypoglycaemia in athletes with diabetes mellitus.
PubMedID- 25647516 This study describes demographic characteristics, comorbidities, and hypoglycemia events in patients with type 2 diabetes mellitus (t2dm) identified using 2011 medicare 5% standard analytical files.
PubMedID- 22371161 Continuous subcutaneous insulin infusion (csii, or insulin pump therapy) reduces hba1c levels and hypoglycaemia in patients with type 1 diabetes mellitus (t1dm) compared with multiple daily insulin injections (mdi).
PubMedID- 24548693 Aims: the global attitude of patients and physicians 2 (gapp2) survey sought to address gaps in understanding about real-world basal insulin-taking behaviour and self-treated hypoglycaemia in patients with type 2 diabetes mellitus.
PubMedID- 21722581 Background: real-time continuous glucose monitoring (rt-cgm) improves hemoglobin a1c (a1c) and hypoglycemia in people with type 1 diabetes mellitus and those with type 2 diabetes mellitus (t2dm) on prandial insulin; however, it has not been tested in people with t2dm not taking prandial insulin.
PubMedID- 24683833 [diagnosis and assessment of hypoglycemia in patients with diabetes mellitus].
PubMedID- 23748506 Background and aim: exenatide is a glucagon-like peptide-1 receptor agonist demonstrated to improve glycemic control with low hypoglycemia risk in patients with type 2 diabetes mellitus.
PubMedID- 21231863 The objective of this study was to compare healthcare utilization, costs, adherence, and hypoglycemia rates in patients with type 2 diabetes mellitus (t2dm) initiating rapid-acting insulin analog (raia) using prefilled pen versus vial/syringe.
PubMedID- 25287289 hypoglycaemia in diabetes mellitus: epidemiology and clinical implications.
PubMedID- 21437076 Minimizing the risk of hypoglycemia in patients with type 2 diabetes mellitus.
PubMedID- 24895268 hypoglycemia in people with diabetes mellitus (dm) has been potentially linked to cardiovascular morbidity and mortality.
PubMedID- 23497433 However this intensive diabetes treatment could be associated with an increased risk of hypoglycemia [5], particularly in patients with type 1 diabetes mellitus and patients with longstanding insulin-treated type 2 diabetes mellitus [6-9].
PubMedID- 21917871 Objective: we hypothesized that opioid receptor blockade with naloxone during antecedent hypoglycemia in patients with type 1 diabetes mellitus (t1dm) would prevent the development of haaf.

Page: 1 2